stockportfolio.pro
Arrowhead Pharmaceuticals, Inc. Net Income 2003–2025
Arrowhead Pharmaceuticals, Inc. (ARWR) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-1.63M | -0.2% | +99.7% |
| FY 2024 | $-599.49M | -16882.4% | -192.0% |
| FY 2023 | $-205.28M | -85.3% | -16.6% |
| FY 2022 | $-176.06M | -72.4% | -25.0% |
| FY 2021 | $-140.85M | -101.9% | -66.6% |
| FY 2020 | $-84.55M | -96.1% | -224.4% |
| FY 2019 | $67.97M | 40.3% | +224.8% |
| FY 2018 | $-54.45M | -337.3% | -58.4% |
| FY 2017 | $-34.38M | -109.5% | +57.9% |
| FY 2016 | $-81.72M | -51614.6% | +11.1% |
| FY 2015 | $-91.94M | -24068.3% | -56.8% |
| FY 2014 | $-58.63M | -33503.0% | -88.3% |
| FY 2013 | $-31.14M | -10729.2% | -47.4% |
| FY 2012 | $-21.13M | -14383.6% | -575.2% |
| FY 2011 | $-3.13M | -1056.6% | +45.8% |
| FY 2010 | $-5.77M | — | +70.1% |
| FY 2009 | $-19.31M | — | +29.1% |
| FY 2008 | $-27.24M | — | +11.3% |
| FY 2007 | $-30.71M | — | -53.9% |
| FY 2006 | $-19.96M | — | -196.5% |
| FY 2005 | $-6.73M | — | -796.3% |
| FY 2004 | $-751,255 | — | -688.8% |
| FY 2003 | $-95,238 | — | — |
Source: Arrowhead Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Arrowhead Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArrowhead Pharmaceuticals, Inc. — frequently asked questions
What is Arrowhead Pharmaceuticals, Inc.'s net income?
Arrowhead Pharmaceuticals, Inc. (ARWR) reported net income of $-1.63M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arrowhead Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.